SCHEMBL4691928

SCHEMBL4691928

NC(=O)c1ccccc1[CH]CCN1CC2CN(C(=O)c3cccc(F)c3)C[C@@H]2C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.41
USP2 O75604 1/20 0.41
PLA2G7 Q13093 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
HCRTR2 O43614 2/20 0.39
HCRTR1 O43613 1/20 0.39
CYP2D6 P10635 3/20 0.39
GRIN2B Q13224 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4694455 0.89 CHRNB2 (0.44) SMN1; SMN2ALDH1A1HPGD
SCHEMBL4691301 0.87 HCRTR1 (0.44) HCRTR2HCRTR1
SCHEMBL4696365 0.86 GRM5 (0.38) ALDH1A1HCRTR2HCRTR1GRIN2B
SCHEMBL3284141 0.83 CCR5 (0.42) HCRTR2HCRTR1
SCHEMBL4691673 0.82 HCRTR1 (0.38) HCRTR2HCRTR1
SCHEMBL4692750 0.81 ALDH1A1 (0.44) USP2SMN1; SMN2ALDH1A1HCRTR1CYP2D6
SCHEMBL4690222 0.81 CHRNA4 (0.46) ALDH1A1HCRTR2HCRTR1
SCHEMBL4691802 0.81 CCR5 (0.48) SMN1; SMN2ALDH1A1HCRTR2HCRTR1HPGD
SCHEMBL4689903 0.81 P2RX7 (0.41) CA12CA1CA2CA7CA9
SCHEMBL4690512 0.80 ALDH1A1 (0.43) ALDH1A1HCRTR2HCRTR1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed